Segall Bryant & Hamill, LLC Amgen Inc Transaction History

Segall Bryant & Hamill, LLC

$7.16 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $53,569 - $66,507	-245 Reduced 0.87%	27,800 $7.47 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $142,275 - $168,237	-664 Reduced 2.31%	28,045 $6.23 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $31,610 - $38,528	140 Added 0.49%	28,709 $6.94 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $145,205 - $184,500	634 Added 2.27%	28,569 $7.5 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $26,261 - $29,618	117 Added 0.42%	27,935 $6.3 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $122,507 - $136,328	-531 Reduced 1.87%	27,818 $6.77 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $440,074 - $486,837	-2,007 Reduced 6.61%	28,349 $6.86 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $910,472 - $1.04 Million	-4,578 Reduced 13.1%	30,356 $6.83 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $1.76 Million - $2.06 Million	8,269 Added 31.01%	34,934 $7.43 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $3.17 Million - $3.51 Million	-13,562 Reduced 33.71%	26,665 $6.5 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $4.2 Million - $4.89 Million	-18,917 Reduced 31.98%	40,227 $10 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $1.23 Million - $1.47 Million	-5,694 Reduced 8.78%	59,144 $13.6 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $360,657 - $401,080	-1,537 Reduced 2.32%	64,838 $16.5 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $1.13 Million - $1.39 Million	-5,731 Reduced 7.95%	66,375 $15.7 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $1.36 Million - $1.8 Million	-7,451 Reduced 9.37%	72,106 $14.6 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $823,441 - $1.06 Million	-4,352 Reduced 5.19%	79,557 $19.2 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $611,474 - $732,673	-3,512 Reduced 4.02%	83,909 $16.2 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $99,519 - $116,659	597 Added 0.69%	87,421 $0
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $379,284 - $427,536	-2,097 Reduced 2.36%	86,824 $0
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $353,767 - $412,959	-1,983 Reduced 2.18%	88,921 $17.3 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $849,369 - $957,551	-4,584 Reduced 4.8%	90,904 $0
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $14.4 Million - $16.2 Million	86,599 Added 974.23%	95,488 $0
Q1 2018 May 16, 2018	SELL	$169.43 - $198.0 $24,736 - $28,908	-146 Reduced 1.62%	8,889 $0
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $4,557 - $5,091	27 Added 0.3%	9,035 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.51 Million - $1.72 Million	9,008	9,008 $0

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account